Apellis Pharmaceuticals

📍 Waltham, United States🗓 Founded 2008👥 811 employees
Biotechnology Research🌐 apellis.com
Website LinkedIn
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. For more information, please visit http://apellis.com.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Apellis Pharmaceuticals founded?
Apellis Pharmaceuticals was founded in 2008.
What industry is Apellis Pharmaceuticals in?
Apellis Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Apellis Pharmaceuticals based?
Apellis Pharmaceuticals is headquartered in Waltham, United States.